Aviva’s Covetrus, Inc. Common Stock CVET Stock Holding History

Aviva’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-22,990	Closed	-$732K	–	809
2019 Q1	$732K	Buy	+22,990	New	+$816K	﹤0.01%	720

Other funds holding CVET

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Aviva's CVET Position: Q2 2019 in Review

Aviva sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2019, closing a stake of 22,990 shares — an estimated $732K sold.

Aviva first reported a position in CVET in Q1 2019 and held it in 1 quarter. The position peaked at $732K in Q1 2019. 321 funds tracked by Wall St. Rank hold CVET as of Q2 2019.

Aviva reported no remaining Covetrus, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Aviva sold 22,990 Covetrus, Inc. Common Stock shares in Q2 2019, an estimated $732K.
Aviva first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
Aviva's Covetrus, Inc. Common Stock position peaked at $732K in Q1 2019.
321 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2019.

Based on Aviva's 13F filing for Q2 2019, filed 30 Jul 2019.